Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-04-24
1999-08-03
Chang, Ceila
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514252, 514318, 514326, 514331, 544238, 546193, 546213, 546230, 546239, A61K 31445, C07D21134
Patent
active
059325941
ABSTRACT:
A compound of the formula: or a pharmaceutically acceptable salt thereof,
wherein Y is a direct link, --(CH.sub.2 --, --(CH.sub.2).sub.2 --, --CH.sub.2 O-- or CH.sub.2 S--; R is --CN or --CONH.sub.2 ;
and R.sup.1 is a group of the formula: ##STR1## where R.sup.2 and R.sup.3 are each independently H, C.sub.1 -C.sub.4 alkyl, C.sub.1 -C.sub.4 alkoxy, --(CH.sub.2).sub.n OH, halo, trifluoromethyl, cyano, --(CH.sub.2).sub.n NR.sup.4 R.sup.5, --CO(C.sub.1 -C.sub.4 alkyl), --OCO(C.sub.1 -C.sub.4 alkyl), --CH(OH) (C.sub.1 -C.sub.4 alkyl), --C(OH) (C.sub.1 -C.sub.4 alkyl).sub.2, --SO.sub.2 NH.sub.2, --(CH.sub.2).sub.n CONR.sup.4 R.sup.5 or --(CH.sub.2).sub.n COO(C.sub.1 -C.sub.4 alkyl; R.sub.4 and R.sup.5 are each independently H or C.sub.1 -C.sub.4 alkyl; n is 0, 1 or 2;
and "Het" is pyridyl, pyrazinyl or thienyl.
The compounds are muscarinic receptor antagonists usedful in the treatment of diseases associated with the altered motility and/or tone of smooth muscle, especially irritable bowel syndrome.
REFERENCES:
patent: 4002766 (1977-01-01), Welstead, Jr.
patent: 4032642 (1977-06-01), Duncan, Jr. et al.
patent: 4242261 (1980-12-01), Cale, Jr.
patent: 4481207 (1984-11-01), Manoury et al.
patent: 4594343 (1986-06-01), Shanklin, Jr. et al.
patent: 4950674 (1990-08-01), Yanni et al.
patent: 5070087 (1991-12-01), Teng
patent: 5096890 (1992-03-01), Cross
patent: 5192765 (1993-03-01), Alker et al.
patent: 5233053 (1993-08-01), Cross et al.
patent: 5281601 (1994-01-01), Cross
patent: 5344835 (1994-09-01), Alker
patent: 5486527 (1996-01-01), Alker
Chemical Abstracts; 90 (1979); Abstract No. 203878y.
Katritzky et al.; "Comprehensive Heterocyclic Chemistry"; Pergamon Press; vol. 3, pp 959-960 (1984).
Walsh et al.; J. Med. Chem., 32, 105-118 (1989).
Goodman et al., The Pharmacologic Basis of Therapeutics, Pergamon Press, p. 123 (1990).
Cross Peter Edward
MacKenzie Alexander Roderick
Benson Gregg C.
Chang Ceila
Jones James T
Pfizer Inc.
Richardson Peter C.
LandOfFree
Muscarinic receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Muscarinic receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Muscarinic receptor antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-849785